News and events at the NDS Bioresource
Upcoming Events
2nd Annual NDS Bioresource Symposium
Planning is underway for our 2nd Annual NDS Bioresource Symposium, scheduled for January 2027. Please check back again soon to see when registration will open.
Previous Events
Inaugural NDS Bioresource Symposium (January 2026)
January this year saw our first ever symposium, hosted at the Richard Doll Building. Intended to highlight and celebrate the fantastic work of the NDSB team and to demonstrate how they contribute to world-leading science, we heard from a broad range of speakers from around Oxford as well as further afield.
Attended by researchers, professional support staff, clinicians, patients, charities and representatives from industry, our inaugural symposium was a wonderful celebration of all things Bioresource, and we received overwhelmingly positive feedback! An especial highlight was the incredible keynote talk from Professor Joakim Lundeberg who delivered this year's Burdett Lecture. A pioneer in the field of spatial -omics analysis, many in the audience were thrilled to hear from Professor Lundeberg not only about advances in his group's research, but also about where he saw the field progressing to.
We were also incredibly thrilled to host as members of our delegation patients who have previously contributed to our biobanks and the clinical trials we have supported. We will look to our next symposium to be able to highlight the invaluable contributions patients make to medical research - watch this space!
NDSB News
Green Impact Gold Award
There is a strong NDS Bioresource presence on the departmental Green Impact committee, who this year were awarded the Green Impact Gold Award from the university. Jessica Doondea, Chair of the NDS Green Committee, summarises another successful year of NDS sustainability in her blog post, Growing greener: Another successful year for sustainability at NDS.
NDSB team contribute to landmark prostate cancer study
Findings from the landmark Articulate Pro study were published this year. NDS Bioresource team members Clare Dunstan and Kate Milosevic-Hutton were pleased to be involved in the valuable study that ultimately demonstrated the potential for Artificial Intelligence to improve and standardise prostate cancer diagnosis. Led by Professor Clare Verrill, you can read more about this landmark study in the 'Study shows AI can be safely deployed in NHS prostate cancer diagnosis' news story, where there is also a link to the paper.